STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

CIK 1403708

EVOKE PHARMA, INC.
CIK 0001403708 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
81.2
composite ยท 3 signals ยท TRIGGERED

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-01 ยท FY 2024-12-31 ยท TRIGGERED56.3

Earnings quality

Beneish M-Score -1.54 exceeds the -1.78 manipulation threshold
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2025-03-13) โ†—
Evidence โ€” inputs and thresholds
{
  "m_score": -1.543,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 1,
    "GMI": 1,
    "AQI": 0.469,
    "SGI": 1.978,
    "DEPI": 1,
    "SGAI": 0.623,
    "LVGI": 0.434,
    "TATA": 0.006
  },
  "defaulted_to_neutral": [
    "DSRI",
    "GMI",
    "DEPI"
  ],
  "sloan_accruals": 0.0087,
  "inputs": {
    "revenue_t": 10249415,
    "revenue_t1": 5180630,
    "total_assets_t": 17519007,
    "net_income_t": -5352194,
    "cfo_t": -5458742
  },
  "stale": false,
  "latest_filing_period": "2024-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1403708/000095017025038712/0000950170-25-038712-index.htm",
    "form": "10-K",
    "filed": "2025-03-13"
  }
}
P-13 ยท FY 2024-12-31 ยท TRIGGERED100.0

Zombie / distress

Zombie: interest coverage below 1.0x for 4 consecutive years
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2025-03-13) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2024-12-31": -10.38,
    "2023-12-31": -14.862,
    "2022-12-31": -15.572,
    "2021-12-31": -16.302
  },
  "consecutive_years_below_1": 4,
  "altman_z_double_prime": -22.689,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -5204137,
    "interest_expense_t": 501370
  },
  "stale": false,
  "latest_filing_period": "2024-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1403708/000095017025038712/0000950170-25-038712-index.htm",
    "form": "10-K",
    "filed": "2025-03-13"
  }
}
P-12 ยท FY 2024-12-31 ยท CLEAN3.0

Restatement predictor

F-Score 0.09 โ€” at or below the population base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2025-03-13) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 0.089,
  "probability": 0.00033,
  "components": {
    "rsst": 0.0087,
    "drec": null,
    "dinv": -0.003,
    "soft": 0.2239,
    "dcs": 0.9784,
    "droa": 0.7969,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2024-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1403708/000095017025038712/0000950170-25-038712-index.htm",
    "form": "10-K",
    "filed": "2025-03-13"
  }
}